Systemic administration of anti-CD20 indirectly reduces B cells in the inflamed meninges in a chronic model of central nervous system autoimmunity

被引：0
|
作者：
Kerfoot, Steven [1 ]
Tesfagiorgis, Yodit [1 ]
Kemal, Eden A. [1 ]
Craig, Heather C. [1 ]
Parham, Kate A. [1 ]
机构：
[1] Univ Western Ontario, London, ON, Canada
来源：
JOURNAL OF IMMUNOLOGY | 2023年 / 210卷 / 01期
关键词：
D O I：
10.4049/jimmunol.210.Supp.85.05
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Systemic administration of anti-CD20 indirectly reduces B cells in the inflamed meninges in a chronic model of central nervous system autoimmunity
    Tesfagiorgis, Yodit
    Kemal, Eden A.
    Craig, Heather C.
    Parham, Kate A.
    Kerfoot, Steven M.
    JOURNAL OF NEUROIMMUNOLOGY, 2024, 387
  • [2] Low-dose Subcutaneous Anti-CD20 Therapy Effectively Depletes B Cells and Ameliorates Central Nervous System Autoimmunity
    Smith, Paul
    Huck, Catherine
    Wegert, Vanessa
    Schmid, Cindy
    Dunn, Robert
    Leppert, David
    Wallstroem, Erik
    NEUROLOGY, 2017, 88
  • [3] Low-dose Subcutaneous Anti-CD20 Therapy Effectively Depletes B Cells and Ameliorates Central Nervous System Autoimmunity
    Smith, Paul
    Huck, Catherine
    Wegert, Vanessa
    Schmid, Cindy
    Dunn, Robert
    Leppert, David
    Wallstroem, Erik
    NEUROLOGY, 2017, 88
  • [4] Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system
    Tokunaga, Mikiko
    Saito, Kazuyoshi
    Kawabata, Daisuke
    Imura, Yoshitaka
    Fujii, Takao
    Nakayamada, Shingo
    Tsujimura, Shizuyo
    Nawata, Masao
    Iwata, Shigeru
    Azuma, Taeko
    Mimori, Tsuneyo
    Tanaka, Yoshiya
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (04) : 470 - 475
  • [5] Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis Is Intrathecal Anti-CD20 a Therapeutic Option?
    Fereidan-Esfahani, Mahboobeh
    Brueck, Wolfgang
    Weber, Martin S.
    JAMA NEUROLOGY, 2015, 72 (12) : 1407 - 1408
  • [6] Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.
    Tanaka, Y
    Tokunaga, M
    Kawabata, D
    Imura, Y
    Fujii, T
    Nawata, M
    Tsujimura, S
    Nakayamada, S
    Mimoro, T
    Saito, K
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S191 - S191
  • [7] Anti-CD20 B cell depletion in immune intervention of central nervous system autoimmune disease
    Weber, M. S.
    Prod'homme, T.
    Karnezis, T.
    Patarroyo, J. C.
    Hemmer, B.
    Linington, C.
    Bernard, C. C. A.
    Martin, F.
    Zamvil, S. S.
    JOURNAL OF NEUROLOGY, 2008, 255 : 36 - 36
  • [8] Anti-CD20 B cell depletion in immune intervention of central nervous system autoimmune disease
    Weber, Martin
    Prod'homme, Thomas
    Karnezis, Tara
    Patarroyo, Juan
    Rundle, Cynthia
    Danilenko, Dimitry
    Slavin, Anthony
    Linington, Christopher
    Bernard, Claude
    Martin, Flavius
    Zamvil, Scott
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 164 - 164
  • [9] Imaging and Therapy with Rituximab Anti-CD20 Immunotherapy in an Animal Model of Central Nervous System Lymphoma
    Muldoon, Leslie L.
    Lewin, Seth J.
    Dosa, Edit
    Kraemer, Dale F.
    Pagel, Michael A.
    Doolittle, Nancy D.
    Neuwelt, Edward A.
    CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2207 - 2215
  • [10] Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity
    Lehmann-Horn, Klaus
    Kinzel, Silke
    Feldmann, Linda
    Radelfahr, Florentine
    Hemmer, Bernhard
    Traffehn, Sarah
    Bernard, Claude C. A.
    Stadelmann, Christine
    Brueck, Wolfgang
    Weber, Martin S.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2014, 1 (07): : 490 - 496
12345